Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA ...

This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce the risk of stroke and deep vein thrombosis.

The FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday.

The USFDA inspection was conducted from March 17 to 21 at the Alembic Pharma API-III facility located at Karakhadi.

The approval covers the norepinephrine bitartrate injection 4 mg/4 mL (1 mg/mL) single-dose vial, which can now be ...

The following is a summary of “Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-analysis of Randomized Trials,” published in the January 2025 issue of ...

Stocks like Ola Electric Mobility, Grasim Industries, RHI Magnesita India, Apollo Hospitals Enterprise, Walchandnagar Industries, ABB India, Mindteck India, Ambuja Cements, Oil and Natural Gas ...

Further, the per-day toll revenue for February 2025 increased 18% YoY to Rs 18.9 crore per day, compared to Rs 15.9 crore per day ... The pharma major has launched Rivaroxaban tablets (USP, 2.5 mg) in ...

Novartis' balance sheet strengthens amid continued strong demand for Entresto, Kesimpta, and Kisqali Novartis' revenue was about $13.15 billion in the fourth quarter of 2024, up 15.1% year-over ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.